Cancer Research

Can MR Cytometry and AI Improve Breast Cancer Diagnosis?
Tech & Innovation Can MR Cytometry and AI Improve Breast Cancer Diagnosis?

Feature selection techniques like LASSO and PCA are essential for filtering noise from the vast datasets generated by high-resolution radiomic analysis. This realization sits at the heart of a transformative shift in medical imaging, where clinicians are moving away from subjective visual

Why Is Bowel Cancer Rising in Adults Under 50?
Tech & Innovation Why Is Bowel Cancer Rising in Adults Under 50?

In partnership with the health science company ZOE, researchers are now tracking brand-specific food consumption to determine if certain chemical additives contribute to cancer risk. For decades, bowel cancer was almost exclusively a concern for the elderly, with the vast majority of cases

Can Steroid Response Predict Survival in Brain Lymphoma?
Tech & Innovation Can Steroid Response Predict Survival in Brain Lymphoma?

Primary central nervous system lymphoma presents a unique clinical paradox where a common steroid used for brain swelling acts as a potent cytotoxic agent that can cause tumors to vanish completely before a diagnosis is secured. This malignancy, primarily manifesting as a diffuse large B-cell

Can CAR-T Therapy Innovation Bridge the Gap in Cancer Care?
Research & Development Can CAR-T Therapy Innovation Bridge the Gap in Cancer Care?

A landmark 300 billion won donation from the late Samsung Chairman Lee Kun-hee has established a vital safety net for pediatric cancer patients across South Korea. This massive philanthropic contribution arrived at a critical juncture for families facing the devastating reality of

Regions Bank Pledges $2.5 Million to UMMC Cancer Center
Management & Regulatory Regions Bank Pledges $2.5 Million to UMMC Cancer Center

Regions Bank, a member of the S&P 500 with $161 billion in assets, is leveraging its financial footprint to address the systemic health challenges facing the Southern United States. This commitment takes the form of a historic $2.5 million pledge to the University of Mississippi Medical Center,

How Effective Is Sacituzumab Govitecan in Metaplastic Breast Cancer?
Research & Development How Effective Is Sacituzumab Govitecan in Metaplastic Breast Cancer?

Even after adjusting for age and prior therapy lines, metaplastic histology remains a clear indicator of a poor response to the Trop-2-directed antibody-drug conjugate sacituzumab govitecan. This finding, derived from a comprehensive retrospective analysis at the Massachusetts General Hospital

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later